Clinical characteristics of fibroblast growth factor receptor 3 antibody‐related polyneuropathy: a retrospective study

Abstract

The FGFR3 antibody appears not to be restricted to sensory neuropathy only. Its role in the pathogenicity of chronic inflammatory neuropathies is not yet well established and, although there may be a role for immunotherapy, larger studies are warranted.